The filing signals intent to sell, but the sale may not occur. Monitor subsequent Form 4 filings to confirm execution and track any pattern of insider selling.
INCY drugs
INCY drug pipeline →How the stock moved after the report
NEUTRAL VIEWSTOCK BELOW ENTRY AT T+5- T+0 · Nov 9 $121.89entry
- T+1 · 7d ago −1.30%α −0.94% · $120.30
- T+5 · 16h ago −1.33%α +0.36% · $120.27
- T+20 · in 21d Pending
- T+60 · in 3mo Pending
Price Chart
How similar events traded
Executive Summary
Steven H. Stein, an officer of Incyte Corp, filed a Form 144 notice of intent to sell 240,193 shares of common stock, with an approximate market value of $28.3 million based on the filing date. The shares were acquired through exercise of stock options. This represents a significant insider sale relative to recent insider activity.
Key Facts
- Filer: Steven H. Stein, an officer of Incyte Corp
- Proposed sale: 240,193 shares of common stock
- Approximate market value: $28,345,175.93
- Shares acquired via exercise of stock options on November 6, 2026
- Sale intended to be executed on or after November 6, 2026
- Broker: Morgan Stanley Smith Barney LLC Executive Financial Services
- Recent insider activity (30 days prior: 2 sells totaling $370K)
- Market cap: $25.0B; proposed sale represents ~0.11% of market cap
Financial Impact
Proposed sale of 240,193 shares valued at approximately $28.3 million, representing about 0.11% of Incyte's $25.0B market cap.
Risk Factors
- Insider sale may signal reduced confidence or portfolio diversification; however, the sale is small relative to market cap.
- Form 144 is an intent to sell; the actual sale may not happen, reducing the signal's reliability.
Market Snapshot
Investment Themes
Documents Analyzed
This report is based on 3 SEC documents filed with EDGAR.
| Document | Accession Number |
|---|---|
| 144 Filing (Primary) | 0001950047-26-010777 |
| Document: 0001950047-26-010777-index.html | 0001950047-26-010777 |
| Document: 0001950047-26-010777.txt | 0001950047-26-010777 |
Track record
18 reports on INCY
2 of 3 bullish or bearish reports moved the stock their way by T+60. Best: +23.70% at T+60 after the Jun 8, 2026 report. 4 of 5 went positive at some point.
Filters
- Nov 16, 2026today 144 Neutral 2/10 Entry $118.50 Now $120.27 +1.49% settles Feb 16
- Nov 13, 20263d ago 144 Neutral 2/10 Entry $123.09 Now $120.27 −2.29% settles Feb 12
- Nov 13, 20263d ago 8-K Neutral 3/10 Entry $119.45 Now $120.27 +0.69% settles Feb 12
- Nov 12, 20264d ago SC 13G/A Neutral 2/10 Entry $120.97 Now $120.27 −0.58% settles Feb 11
- Nov 10, 20266d ago Insider Cluster Neutral 2/10 Entry $122.27 Now $120.27 −1.64% settles Feb 9
- Nov 6, 202610d ago 144 Neutral 4/10 Viewing Entry $121.89 Now $120.27 −1.33% settles Feb 5
- Nov 3, 202613d ago 144 Neutral 2/10 Entry $122.85 Now $120.27 −2.10% settles Feb 2
- Oct 29, 202618d ago 8-K Bullish 6/10 Entry $116.80 Now $120.27 +2.97% settles Jan 27
- Oct 23, 202624d ago Institutional Cluster Bullish 4/10 Entry $115.71 Now $120.27 +3.94% settles Jan 21
- Aug 14, 202613w ago Insider Cluster Bearish 4/10 Entry $123.50 to $120.30 Now $120.27 +2.62% ▲ +2.59% −0.35% vs SPY
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers